Composition and immunological properties of the protein fraction of A36, a major antigen complex of Mycobacterium paratuberculosis.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 1380177)

Published in Scand J Immunol on August 01, 1992

Authors

M De Kesel1, P Gilot, M Coene, C Cocito

Author Affiliations

1: Microbiology & Genetics Unit, University of Louvain, Medical School, Brussels, Belgium.

Articles citing this

Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clin Microbiol Rev (2001) 3.58

Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol (1995) 2.77

Paratuberculosis. Clin Microbiol Rev (1994) 2.58

Expression and immunogenicity of proteins encoded by sequences specific to Mycobacterium avium subsp. paratuberculosis. J Clin Microbiol (2004) 1.28

Characterization of novel coding sequences specific to Mycobacterium avium subsp. paratuberculosis: implications for diagnosis of Johne's Disease. J Clin Microbiol (2004) 1.26

Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol (1993) 1.18

Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease. J Clin Microbiol (1993) 1.17

Development of species-specific enzyme-linked immunosorbent assay for diagnosis of Johne's disease in cattle. J Clin Microbiol (1994) 1.11

Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies. Infect Immun (1997) 1.11

Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96

Characterization of a 34-kilodalton protein of Mycobacterium leprae that is isologous to the immunodominant 34-kilodalton antigen of Mycobacterium paratuberculosis. Infect Immun (1998) 0.91

Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diagn Lab Immunol (1994) 0.86

Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG. Clin Diagn Lab Immunol (1994) 0.80

Analysis of tuberculous meningitis cases by an immunoblotting assay based on a mycobacterial antigen complex. Clin Diagn Lab Immunol (1994) 0.75

Specificity of the 34-kilodalton immunodominant protein of Mycobacterium avium sp. paratuberculosis. Clin Diagn Lab Immunol (1999) 0.75

Articles by these authors

The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol Rev (2000) 2.71

Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev (1979) 2.65

Paratuberculosis. Clin Microbiol Rev (1994) 2.58

Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem (1992) 1.54

Preparation of a specific RNA probe for detection of Mycobacterium paratuberculosis and diagnosis of Johne's disease. J Clin Microbiol (1993) 1.38

Isolation and sequencing of the gene coding for an antigenic 34-kilodalton protein of Mycobacterium paratuberculosis. J Bacteriol (1993) 1.18

Cloning and expression of portions of the 34-kilodalton-protein gene of Mycobacterium paratuberculosis: its application to serological analysis of Johne's disease. J Clin Microbiol (1993) 1.17

Typing of Listeria monocytogenes strains by repetitive element sequence-based PCR. J Clin Microbiol (1999) 1.17

Comparative analysis of the genomes of intestinal spirochetes of human and animal origin. Infect Immun (1989) 1.14

Preparation and properties of antigen 60 from Mycobacterium bovis BCG. Clin Exp Immunol (1986) 1.13

Development of species-specific enzyme-linked immunosorbent assay for diagnosis of Johne's disease in cattle. J Clin Microbiol (1994) 1.11

Influence of vasopressin on learning and memory. Lancet (1978) 1.10

Metabolism of macromolecules in bacteria treated with virginiamycin. J Gen Microbiol (1969) 1.08

Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes. J Biol Chem (1987) 1.04

The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes. J Antimicrob Chemother (1989) 1.04

Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria. J Infect Dis (1985) 1.04

Mechanism of action of streptogramins and macrolides. Drugs (1996) 1.03

The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J Biol Chem (1992) 0.97

Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96

A microanalytical procedure for determination of the base composition of DNA. Eur J Biochem (1985) 0.95

Interference of virginiamycin M with the initiation and the elongation of peptide chains in cell-free systems. Biochim Biophys Acta (1974) 0.95

Duplex PCR for differential identification of Mycobacterium bovis, M. avium, and M. avium subsp. paratuberculosis in formalin- fixed paraffin-embedded tissues from cattle. J Clin Microbiol (2000) 0.94

Mycobacterial proliferation in macrophages is prevented by incubation with lymphocytes activated in vitro with a mycobacterial antigen complex. Eur J Immunol (1991) 0.94

Induction of cellular immune reactions by A36, an antigen complex of Mycobacterium paratuberculosis: comparison of A36 and johnin components. Scand J Immunol (1992) 0.93

Immunization of mice with the antigen A60 of Mycobacterium bovis BCG. Clin Exp Immunol (1992) 0.92

Definitive evidence for the actual contribution of yeast in the transformation of neutral precursors of grape aromas. J Agric Food Chem (2001) 0.90

Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis. Infect Immun (1993) 0.90

Chemical composition of antigen 60 from Mycobacterium bovis BCG. Scand J Immunol (1986) 0.90

Virginiamycin M, a specific inhibitor of the acceptor site of ribosomes. Biochimie (1971) 0.90

Immunological properties of antigen 60 of BCG. Induction of humoral and cellular immune reactions. Scand J Immunol (1987) 0.89

Immunological relatedness of ribosomes from mycobacteria, nocardiae and corynebacteria, and microorganisms in leprosy lesions. Infect Immun (1978) 0.89

Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients. Eur J Epidemiol (1985) 0.88

Formation of chloroplast ribosomes and ribosomal RNA in Euglena incubated with protein inhibitors. Exp Cell Res (1973) 0.88

Structure and function of cytoplasmic organelles in transiently and permanently bleached Euglena. Exp Cell Res (1973) 0.87

Thermostable macromolecular antigens from mycobacteria. Can J Microbiol (1994) 0.87

Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M. Proc Natl Acad Sci U S A (1980) 0.87

The properties of virginiamycin-resistant mutants of Bacillus subtilis. J Gen Microbiol (1973) 0.86

A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes. Mol Gen Genet (1978) 0.86

Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diagn Lab Immunol (1994) 0.86

Affinity labeling of the virginiamycin S binding site on bacterial ribosome. Biochemistry (1990) 0.85

Action of erythromycin and virginiamycin S on polypeptide synthesis in cell-free systems. Biochim Biophys Acta (1988) 0.85

Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. Biochim Biophys Acta (1989) 0.85

Pressure dissociation of bacterial ribosomes and reassociation of ribosomal subunits. Mol Gen Genet (1978) 0.85

Formation and decay of polyribosomes and ribosomes during the inhibition of protein synthesis and recovery. Biochimie (1971) 0.85

Isolation and characterization of a novel glucuronosyl diacylglycerol from Mycobacterium smegmatis. Biochim Biophys Acta (1993) 0.84

Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes. J Biol Chem (1983) 0.84

The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins. Biochim Biophys Acta (1983) 0.84

Identification of a salvage pathway for D-arabinose in Mycobacterium smegmatis. Eur J Biochem (1988) 0.83

Formation of ribosomal particles in virginiamycin sensitive and resistant mutants of Bacillus subtilis. Biochimie (1973) 0.83

The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. Mol Gen Genet (1978) 0.83

Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems. J Antimicrob Chemother (1985) 0.83

The action of virginiamycin on nucleic acid and protein synthesis in Bacillus subtilis infected with bacteriophage 2C. J Gen Microbiol (1969) 0.82

Intrathecal synthesis of anti-mycobacterial antibodies in patients with tuberculous meningitis. An immunoblotting study. J Neurol Neurosurg Psychiatry (1990) 0.82

Saccharomyces cerevisiae cell fatty acid composition and release during fermentation without aeration and in absence of exogenous lipids. Int J Food Microbiol (1999) 0.82

Properties of microorganisms isolated from human leprosy lesions. Rev Infect Dis (1983) 0.82

Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. Nucleic Acids Res (1994) 0.82

Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides. Biochim Biophys Acta (1988) 0.82

Origin and metabolic properties of the RNA species formed during the replication cycle of virus 2C. J Virol (1974) 0.82

Serological analysis of pulmonary and extrapulmonary tuberculosis with enzyme-linked immunosorbent assays for anti-A60 immunoglobulins. Clin Infect Dis (1994) 0.82

The ribosomal cycle in bacteria treated with an inhibitor of protein synthesis. Biochimie (1973) 0.82

Comparative analysis of three sensitins used in cutaneous testing for tuberculosis and paratuberculosis in cattle. FEMS Microbiol Lett (1993) 0.82

Delayed hypersensitivity reactions by the mycobacterial antigen A60 and cutaneous testing in tuberculosis. Med Microbiol Immunol (1989) 0.81

Analysis of fluorescence quenching of ribosome-bound virginiamycin S. J Biol Chem (1984) 0.81

DNA methylation in leprosy-associated bacteria: Mycobacterium leprae and Corynebacterium tuberculostearicum. Med Microbiol Immunol (1988) 0.81

Serological analysis of human tuberculosis by an ELISA with mycobacterial antigen 60. Scand J Infect Dis (1990) 0.81

Structure of the wall polysaccharide isolated from a group of corynebacteria. Eur J Biochem (1982) 0.81

Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit. Biochim Biophys Acta (1981) 0.80

Prolongation of canine kidney-homograft survival by heterologous ribonucleic acid (RNA) perfusion. Br J Surg (1969) 0.80

Analysis of mycolic acids from a group of corynebacteria by capillary gas chromatography and mass spectrometry. Eur J Biochem (1982) 0.80

Chemical identification of some cell-wall components of microorganisms isolated from human leprosy lesions. Zentralbl Bakteriol Mikrobiol Hyg A (1981) 0.80

Macromolecule metabolism and photosynthetic functions in blue-green algae treated with virginiamycin, an inhibitor of protein synthesis. Antimicrob Agents Chemother (1974) 0.80

Immunological analysis of the components of the antigen complex A60 of Mycobacterium bovis BCG. Clin Diagn Lab Immunol (1994) 0.80

Characterization of a Mycobacterium bovis BCG insertion sequence related to the IS21 family. FEMS Microbiol Lett (1999) 0.79

Meabolism of nucleic acids in uninfected fibroblasts incubated in vitro with rat interferon. Life Sci (1965) 0.79

Thermogravimetric study of thermal decontamination of soils polluted by hexachlorobenzene, 4-chlorobiphenyl, naphthalene, or n-decane. J Hazard Mater (1999) 0.78

Size and homology of the genomes of leprosy-derived corynebacteria, Mycobacterium leprae, and other corynebacteria and mycobacteria. J Med Microbiol (1988) 0.78

Physical map of phage 2 C DNA: evidence for the existence of large redundant ends. Eur J Biochem (1983) 0.78

Effect of virginiamycin on the growth cycle of Bdellovibrio. Antimicrob Agents Chemother (1976) 0.78

Comparison of the cytoplasmic antigens of leprosy-derived corynebacteria and some mycobacteria. Scand J Immunol (1983) 0.78

RAPD analysis, serotyping, and esterase typing indicate that the population of Listeria monocytogenes strains recovered from cheese and from patients with listeriosis in Belgium are different. Can J Microbiol (2001) 0.78

Interaction between virginiamycin S and ribosomes is partly provided by a salt bridge with a Mg2+ ion. Biochemistry (1991) 0.77

Ribosome protection by tRNA derivatives against inactivation by virginiamycin M: evidence for two types of interaction of tRNA with the donor site of peptidyl transferase. Biochemistry (1987) 0.77

Biochemical studies with leprosy-derived corynebacteria. Acta Leprol (1983) 0.77

Comparison of the physical maps and redundant ends of the chromosomes of phages 2C, SP01, SP82 and phi e. Eur J Biochem (1983) 0.77